Interim Financial Statements for the Quarter ended 30th June 2025

A Public Quoted Company with limited

liability incorporated in Sri Lanka in 1964.

S H Amarasekera- Chairman

R S Captain

S M Enderby

J R Gunaratne

M P Jayawardena

D T S H Mudalige

P R Saldin

K D Senewiratne

P W Corporate Secretarial (Pvt) Ltd

3/17,Kynsey Road

Colombo 08

T.P 011 4640360

KPMG

Chartered Accountants

32A, Sir Mohamed Macan Markar Mawatha

Colombo 03

Julius & Creasy

Attorneys - at - Law

371, R A De Mel Mawatha, Colombo 03

Heritage Partners

Attorneys - at - Law

04, Malalasekera Pedesa

Colombo 07

Nithya Partners

Attorneys - at -Law

97A, Galle Road, Colombo 03

CIC House

199, Kew Road

Colombo 02

Company Variance Group Variance

% %

30th June

2025

2024

2025

2024

(In Rs.Mns)

Revenue

4,927.40

5,098.53

(3.36)

21,440.94

19,804.93

8.26

Cost of sales

(3,423.28)

(3,555.68)

(3.72)

(15,992.14)

(14,707.54)

8.73

Gross profit

1,504.12

1,542.85

(2.51)

5,448.80

5,097.39

6.89

Other income

485.26

172.52

181.28

214.09

44.17

384.70

Distribution expenses

(703.89)

(686.63)

2.51

(1,885.52)

(1,702.64)

10.74

Impairment loss on trade receivables

(22.59)

(2.08)

986.06

(40.92)

(12.76)

220.69

Administrative expenses

(269.27)

(231.17)

16.48

(959.20)

(885.67)

8.30

Other expenses

-

-

-

(0.25)

(0.02)

1,150.00

Finance income

63.15

71.93

(12.21)

117.90

197.25

(40.23)

Finance cost

(408.22)

(439.99)

(7.22)

(582.61)

(582.35)

0.04

Financing costs (net)

(345.07)

(368.06)

(6.25)

(464.71)

(385.10)

20.67

Gain on bargain purchase

-

-

-

32.09

13.43

138.94

Loss on dilution of investment in associate

-

-

-

(15.25)

(19.61)

(22.23)

Share of profit of equity accounted investees

-

-

-

17.03

21.52

(20.86)

Profit before tax

648.56

427.43

51.73

2,346.16

2,170.71

8.08

Tax expense

(158.69)

(105.73)

50.09

(837.22)

(669.69)

25.02

Profit from continuing operation

489.87

321.70

52.28

1,508.94

1,501.02

0.53

Other comprehensive income

Items that are or may be reclassified to profit or loss

Net gain/(losses) on fair value change in financial assets

7.21

4.63

55.72

(16.89)

37.79

(144.69)

Equity-accounted investees- share of OCI

-

-

-

41.88

52.73

(20.58)

Other comprehensive income for the period (net of tax)

7.21

4.63

55.72

24.99

90.52

(72.39)

Total comprehensive income for the period (net of tax)

496.82

326.28

52.27

1,536.68

1,587.35

(3.19)

Discontinued operations

Profit/(loss) from discontinued operations (net of tax)

Profit for the year

(0.26) (0.05) 420.00 2.75 (4.19) (165.63)

489.61 321.65 52.22 1,511.69 1,496.83 0.99

Earnings per share

Basic/diluted earnings per share (Rs.)

1.29

Earnings per share continuing operation

Basic/diluted earnings per share (Rs.)

1.29

0.85

52.22

3.23

3.29

(1.87)

0.85

52.28

3.22

3.30

(2.30)

Equity holders of the company

489.61 321.65 52.22 1,223.46 1,246.81 (1.87)

Non controlling interests

- - - 288.23 250.02 15.28

489.61 321.65 52.22 1,511.69 1,496.83 0.99

The other comprehensive income attributable to :

Equity holders of the company

7.21 4.63 55.72 36.25 71.00 (48.94)

Non controlling interest

- - - (11.26) 19.52 (157.68)

7.21 4.63 55.72 24.99 90.52 (72.39)

The above figures are provisional and unaudited

Figures in brackets indicate deductions

Statements of Financial Position

Company

Group

30th June

30th June

31st March

30th June

30th June

31st March

As at

2025

2024

2025

2025

2024

2025

Property, plant & equipment 2,654.76 2,318.07 2,638.26 14,476.10

12,545.04 14,052.96

Investment property - - - 2.40

2.40 2.40

Capital work-in-progress 19.09 - 20.13 851.14

51.42 495.64

Biological assets - - - 375.38

458.26 420.94

Intangible assets 21.80 29.70 23.78 591.25

618.40 598.21

Deferred tax assets - - - 18.08

8.56 18.08

Investment in subsidiaries 3,767.26 3,734.96 3,767.26 -

- -

Investment in equity accounted investees 17,123.20 16,380.34 17,123.20 29,557.24

25,162.92 29,350.82

Equity investment at fair value through OCI - - - 0.15

0.15 0.15

Deposits with bank - - - 0.29

0.29 0.29

23,586.11 22,463.07 23,572.63 45,872.03

38,847.44 44,939.49

Inventories 5,366.46 4,228.36 6,081.94 17,854.11

15,710.89 20,718.99

Biological assets - - - 307.71

349.35 247.33

Income tax receivables - - - 0.22

0.29 31.32

Trade receivables 4,788.85 3,954.30 5,144.81 12,403.60

10,409.45 11,987.87

Contract assets 166.73 104.48 166.73 224.66

157.33 224.66

Other receivables 607.99 988.20 659.39 3,289.94

3,562.18 3,829.53

Equity investment at fair value through OCI 75.60 44.69 68.38 432.04

328.95 496.00

Deposits with bank 1,938.64 1,644.47 1,658.80 2,266.81

1,936.48 1,683.27

Cash in hand and at bank 1,195.00 899.79 1,359.85 5,099.94

5,175.42 5,045.47

14,139.27 11,864.29 15,139.90 41,879.03

37,630.34 44,264.44

Assets classified as held for sale 146.27 146.27 146.27 187.95

352.02 187.95

Assets classified as held for distribution 0.20 0.20 0.20 68.41

61.64 64.40

14,285.74 12,010.75 15,286.36 42,135.39

38,044.00 44,516.79

Total assets 37,871.85 34,473.82 38,858.99 88,007.42

76,891.44 89,456.28

Stated capital 1,008.45 1,008.45 1,008.45 1,008.45 1,008.45 1,008.45

Capital reserves 1,158.21 950.24 1,158.21 3,013.27 2,412.46 3,013.27

Revenue reserves 10,814.02 10,256.72 10,317.20 37,378.20 32,793.40 36,097.86

12,980.68 12,215.41 12,483.86 41,399.92 36,214.31 40,119.58

Non-controlling interests - - - 6,434.50 5,371.54 6,307.24

Total equity 12,980.68 12,215.41 12,483.86 47,834.42 41,585.85 46,426.82

Loans and borrowings 1,838.52 72.51 1,554.57 2,517.09 418.76 1,900.90

Retirement benefit obligations 489.22 363.72 472.91 1,669.52 1,364.24 1,609.75

Grants - - - 1.15 1.33 1.20

Deferred tax liabilities 121.92 128.16 57.64 1,719.08 1,642.55 1,660.61

2,449.66 564.39 2,085.12 5,906.84 3,426.88 5,172.46

Trade payables 1,772.19 1,779.08 2,728.86 4,142.26 3,173.20 6,427.23

Contract liabilities 242.32 148.41 242.32 353.47 203.56 353.47

Income tax payable 474.52 122.68 386.40 1,437.96 1,189.81 1,368.62

Accruals and other payables 1,098.25 1,302.25 1,158.86 3,769.79 3,439.32 3,262.95

Contigent consideration payable 108.05 108.05 108.05 108.05 108.05 108.05

Loans and borrowings 18,746.18 18,233.55 19,665.52 24,452.73 23,345.17 26,334.76

22,441.51 21,694.02 24,290.01 34,264.26 31,459.11 37,855.08

Liabilities classified as held for sale - - - - 417.74 -

Liabilities classified as held for distribution - - - 1.90 1.86 1.92

22,441.51 21,694.02 24,290.01 34,266.16 31,878.71 37,857.00

Total liabilities 24,891.17 22,258.41 26,375.13 40,173.00 35,305.59 43,029.46

Total equity and liabilities 37,871.85 34,473.82 38,858.99 88,007.42 76,891.44 89,456.28

Net assets per share (Rs.) 34.24 32.22 32.93 109.21 95.53 105.83

(Sgd. ) Erandi Wickramaarachchi

Group Chief Financial Officer

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.

(Sgd.) S H Amarasekera

Chairman

05th August 2025

Colombo

(Sgd.) D T S H Mudalige

Director

Statement of Changes In Equity

For the period ended 30 June

Company

Stated Capital

Revaluation

Reserve

General Reserves

Fair Value

Reserve

Retained

Earnings

Total

(In Rs. Mns)

As at 01 April 2025

1,008.45

1,158.21

782.60

24.44

9,510.16

12,483.86

Profit for the period

-

-

-

-

489.61

489.61

Other comprehensive income

-

-

-

7.21

-

7.21

As at 30 June 2025

1,008.45

1,158.21

782.60

31.65

9,999.77

12,980.68

As at 01 April 2024 1,008.45 950.24 782.60 (3.14) 9,150.98 11,889.13

Profit for the period - - - - 321.65 321.65

Other comprehensive income - - - 4.63 - 4.63

As at 30 June 2024 1,008.45 950.24 782.60 1.49 9,472.63 12,215.41

As at 01 April 2024

1,008.45

2,412.46

720.31

(33.74)

30,785.65

34,893.14

5,101.74

39,994.88

Profit for the period

-

-

-

-

1,246.81

1,246.81

250.02

1,496.83

Other comprehensive income

-

-

-

22.03

48.97

71.00

19.52

90.52

Adjustment due to change in equity accounted investee

3.36

3.36

0.26

3.62

As at 30 June 2024

1,008.45

2,412.46

720.31

(11.71)

32,084.80

36,214.31

5,371.54

41,585.85

Cash Flow Statements

Company

Group

For the period ended 30 June

2025

2024

2025

2024

(In Rs. MN's)

Cash flow from operating activities

Cash generated from operations (Note A)

766.00

628.89

4,486.08

2,769.13

Interest paid

(406.32)

(438.01)

(568.33)

(573.06)

Retirement benefit costs paid

(3.79)

-

(11.18)

(4.02)

Income tax paid

(6.29)

(28.50)

(651.45)

(464.87)

Net cash inflow from operating activities

349.60

162.38

3,255.12

1,727.18

Cash flow from investing activities

Addition to property, plant & equipment and CWIP

(53.75)

(16.06)

(1,121.60)

(144.20)

Addition to biological assets

-

(76.84)

(145.37)

Proceeds from disposal of property, plant & equipment

-

-

0.17

0.46

Proceeds from disposal of investments

-

-

46.25

-

Proceeds from sale of biological assets

-

-

0.59

-

Dividend received from subsidiaries

192.20

-

-

-

Dividend received from equity accounted investees

198.14

-

215.58

194.42

Dividend received from other financial assets

2.93

166.03

21.85

10.30

Interest income received

63.15

71.93

117.90

197.25

Further investment in associate

-

(68.32)

(351.12)

(79.54)

Other long-term investments

-

-

-

(4.67)

Other short-term investments

-

-

-

(0.74)

Subsidiary dividends to non-controlling interest

-

-

(151.20)

-

investments in banks

(279.84)

(33.23)

(583.54)

(317.77)

Net cash inflow/(outflow) from investing activities 122.83 120.35 (1,881.96)

(289.86)

1,373.16

1,437.32

Net Long term loan received settled (81.92) (2.73) (193.09) (20.27)

Long term loans received - - 400.00 -

Net cash inflow/(outflow) from financing activities (81.92) (2.73) 206.91

(20.27)

Net increase in cash & cash

equivalents during the period 390.51 280.00 1,580.07 1,417.05

Cash & cash equivalents at the beginning of the period (17,941.69) (17,613.76) (20,827.21) (19,498.47)

Cash & cash equivalents at the end of the period (Note B) (17,551.18) (17,333.76) (19,247.14) (18,081.42)

Note A - Cash generated from operations

Profit before tax from continuing operations

648.56

427.43

2,329.32

2,176.89

Profit/(Loss) before interest and tax from discontinued operations

(0.26)

(0.05)

2.89

(4.19)

Adjustments for:

Depreciation on property, plant & equipment

36.91

34.35

253.66

225.14

Amortization of Intangible assets

1.97

1.97

6.96

6.81

Amortization of right use asset

1.38

1.38

15.82

25.37

(Gain) /loss on disposal of property, plant & equipment

-

-

0.23

(0.44)

Provision for retirement benefit

20.10

23.99

70.95

67.57

Amortization of biological assets and change due to harvest

-

-

121.81

191.48

Grants amortised

-

-

(0.05)

(0.04)

Write off of property, plant and equipment

-

-

-

0.05

Interest income

(63.15)

(71.93)

(117.90)

(197.25)

Interest expense

408.22

439.99

579.88

586.46

Share of profit of equity accounted investees

-

-

(17.03)

(21.52)

Dividend income

(393.27)

(166.03)

(21.85)

(10.30)

Operating profit before working capital changes

660.46

691.10

3,224.69

3,046.03

(Increase)/Decrease in trade and other receivables

407.36

(509.62)

235.07

(1,416.26)

Decrease in inventories

715.48

956.36

2,804.50

2,688.57

Decrease in trade and other payables

(1,017.30)

(508.95)

(1,778.18)

(1,549.21)

Cash generated from operations

766.00

628.89

4,486.08

2,769.13

Note B - Analysis of cash & cash equivalents

at the end of the period

Cash in hand and at bank

1,195.00

899.79

5,165.32

5,241.02

Interest bearing short-term borrowings

(18,746.18)

(18,233.55)

(24,412.46)

(23,322.44)

For the Period ended 30th June 2025 2024

(In Rs. Mns)

Operating Segments

The Following table presents revenue, profit information regarding the Group's operating segments.

(a)

Segmental Revenue

Crop Solutions

Agri Produce

Livestock Solutions

Industrial Solutions

Health & Personal Care

9,368.10

1,411.85

4,448.86

1,867.54

4,731.29

8,398.10

1,400.50

4,265.74

1,990.08

4,216.99

Total Revenue

21,827.64

20,271.41

Intra-group sales

(386.70)

(466.48)

Net Revenue 21,440.94 19,804.93

(b)

Segmental Results

Crop Solutions

Agri Produce

Lives stock Solutions

Industrial Solutions

Health & Personal Care

1,209.42

85.39

312.37

329.12

689.89

1,085.28

150.00

497.94

376.64

419.86

Net Segmental Results

2,626.19

2,529.72

Unallocated expenses

(63.28)

(33.42)

Other income

214.09

44.17

Financing costs

(464.71)

(385.10)

Gain on Bargain Purchase

32.09

13.43

Loss on dilution of investment in associate

(15.25)

(19.61)

Share of profit from equity accounted investees

17.03

21.52

Tax expense

(837.22)

(669.69)

Profit from continuing operations

1,508.94

1,501.02

Profit/(loss) from discontinued operations (net of tax)

2.75

(4.19)

Profit for the period

1,511.69

1,496.83

Equity holders of the Company

Non- controlling interest

1,223.46

288.23

1,246.81

250.02

Note :

The above figures are provisional and unaudited.

Figures in brackets indicate deductions.

Company

Group

For the period ended 30 June

2025

2024 2025 2024

(In Rs. Mns)

1

Other Income

Rent income

6.86

6.49 0.24 4.19

Divided income

393.27

166.03 21.85 10.30

Gain on disposal of property, plant and equipment

-

- 0.02 0.46

Direct sales commission

85.13

- 133.58 5.91

Changes in fair value of biological assets

-

- 0.41 -

Grants amortised

-

- 0.04 0.04

Sundry income

-

- 57.95 23.27

485.26

172.52 214.09 44.17

2

Financing Cost (Net)

Finance cost

Interest on loans

406.32

438.01 571.05 567.91

Interest on leases

1.90

1.98 11.56 14.45

408.22

439.99 582.61 582.35

Finance income

Exchange gain

35.21

45.60 62.03 85.19

Interest income

27.94

26.33 55.87 112.06

63.15

71.93 117.90 197.25

Net financing cost

345.07

368.06 464.71 385.10

3

Market Value of Shares

For the three months ended 30th June

2025

2024

Voting

Non-Voting

Voting

Non-Voting

Rs.

Rs.

Rs.

Rs.

Highest

129.00

94.00

84.40

61.30

Lowest

110.00

75.00

70.50

51.50

Period end

127.25

93.40

75.90

57.90

4

Market Capitalisation

Type

No.of Shares

Share price

Capitalisation

Rs.

Rs.

Ordinary Shares

291,600,000

127.25

37,106,100,000

Non-Voting (Class X)

87,480,000

93.40

8,170,632,000

5

Float Adjusted Market Capitalisation

Type

No.of Shares

Share price

Capitalisation

Rs.

Rs.

Ordinary Shares

136,147,684

127.25

17,324,792,789

Non-Voting (Class X)

84,530,840

93.40

7,895,180,456

6

Number of Shares

Number of Shares Share Capital (Rs)

As at end of 31 December

2025

2024 2025 2024

Ordinary Shares

291,600,000

291,600,000 789,750,000 789,750,000

Non-Voting (Class X)

87,480,000

87,480,000 218,700,000 218,700,000

Total

379,080,000

379,080,000 1,008,450,000 1,008,450,000

7

Dividend Paid

8

There have not been any significant changes in the nature of the Contingent Liabilities which were disclosed in the Annual Report for the year ended

31 March 2025.

Notes to the Financial Statements (Cont..)

These Interim Financial Statements have been prepared in accordance with the accounting policies set out in the annual report for the year ended 31 March 2025 and unless otherwise stated are consistent with those followed in the preparation of Financial Statements for the year ended 31 March 2025 and are in compliance with Sri Lanka Accounting Standards 34- Interim Financial Reporting. Presentation and classification of figures for the corresponding period of the previous period have been amended, where relevant to be comparable with those for the current year.

10

Fair value measurement hierarchy

Assets measured at fair value are categorised within level 01 and level 03 of the fair value hierarchy.

As at 30 June 2025 2024 2025 2024

Recurring fair value measurements-

Freehold land

4,729.59 4,657.29

Biological assets

683.09 807.61

Equity investments

432.19 329.10

432.19 329.10 5,412.68 5,464.90

Non-recurring fair value measurements

Net assets classified as held for distribution 254.46 (5.94)

11

Basic/diluted earnings per share is calculated by dividing the net profit for the period attributable to shareholders by the weighted average number

of shares outstanding during the period as required by LKAS - 33, Earning Per Share.

12

CIC applied equity accounting only in respect of CIC and its subsidiaries' holding in JKH, from the quarter ending 31st December 2023.

Rs.Mn

Stated capital Revenue reserves equity parent

As at 30 June 2025

133,078.29 133,284.94 132,431.01 398,794.24

Net assets attributable to CIC Group - 30 June 2025

127.88 128.08 127.26 383.21

Net assets attributable 383.21

Cost of the investment 351.12

Gain on bargain purchase 32.09

John Keells Holdings PLC has exercised its share option scheme and executed share based payments. According to that, listing of new ordinary shares of 34,936,560, CIC Holdings Group share holding percentage got diluted. Accordingly a loss of dilution of Rs.15.25 Mn was charged to the

Income Statement.

Quarter ended 30

June 2025

Rs.Mn

Net assets applicable to CIC Group before dilution

28,021.85

Net assets applicable to CIC Group after dilution

28,006.60

Loss on dilution of investment in John Keells Holdings PLC

(15.25)

13

Other than the above, there were no material events took place since the reporting date which require adjustment to or disclosure in these Financial

Statements.

1

Twenty Largest Shareholders

Name

No. of Shares

Percentage %

Paints & General Industries Limited

155,441,396

53.31

Employee's Provident Fund

26,417,892

9.06

Sampath Bank PLC/ Chacra Capital Holdings (Private) Limited

13,104,960

4.49

Ms. J. Ambani

5,099,192

1.75

Asia Securities (Private) Limited - Trading Account

5,010,660

1.72

Citibank Newyork S/A Norges Bank Account 2

4,258,258

1.46

Senkadagala Finance PLC/ Mr. R.S.H. Nanayakkara & R.M. Nanayakkara

3,500,000

1.20

Mr. H. Yusoof

3,170,959

1.09

Ranavav Holdings (Private) Limited

3,105,963

1.07

Employees Trust Fund Board

2,835,797

0.97

Dr. H.R. Wickremesinghe & Mr. V.K. Wickremasinghe (Deceased)

1,752,242

0.60

Mr. R.P. Weerasooriya

1,550,308

0.53

Amana Bank PLC/ Hi-Line Trading (Private) Limited

1,459,254

0.50

Ms. L.K. Goonewardena

1,403,965

0.48

S.K. Wickremesinghe Trust (Gurantee) Limited

1,360,000

0.47

Colombo Fort Investments PLC

1,245,000

0.43

Ms. N.K.R.H. De Silva

1,135,700

0.39

Union Assurance PLC - Universal Life Fund

1,102,318

0.38

Bank of Ceylon - Ceybank Unit Trust

981,279

0.34

Finco Holdings (Private) Limited

930,887

0.32

234,866,030

80.54

NON-VOTING (CLASS 'X') SHARES

Name

No. of Shares

Percentage %

1

Employee's Provident Fund

11,113,696

12.70

2

Sampath Bank PLC/ Chacra Capital Holdings (Private) Limited

6,184,280

7.07

3

Paints & General Industries Limited

2,905,204

3.32

4

Mr. H. Yusoof

2,839,306

3.25

5

Seylan Bank PLC/ Mr. W.G.U.I. Ranaweera

2,059,290

2.35

6

Winsland Reality (Private) Limited

1,068,121

1.22

7

Union Assurance PLC - Universal Life Fund

1,028,462

1.18

8

Ranavav Holdings (Private) Limited

914,329

1.05

9

Hatton National Bank PLC - NDB Wealth Growth and Income Fund

800,000

0.91

10

Invenco Capital (Private) Limited

781,734

0.89

11

GF Capital Global Limited

641,916

0.73

12

Employees Trust Fund Board

606,985

0.69

13

Seylan Bank PLC/ Mr. A.C. Senanka

602,996

0.69

14

Hatton National Bank PLC - Astrue Alpha Fund

550,000

0.63

15

Malship Ceylon Limited

534,528

0.61

16

HNB Investment Bank (Private) Limited/ Mr. H.A.R. Peiris

525,000

0.60

17

Hatton National Bank PLC/ Mr. G.S.N. Peiris & Ms. I.R. Peiris

518,155

0.59

18

Ms. S. Vasudevan & Mr. S. Vasudevan

500,000

0.57

19

Ms. D. Ramesh & Mr. P. Ramesh

500,000

0.57

20

Lynear Wealth Management/ Mr. H. Yusoof

492,456

0.56

35,166,458

40.20

3

Shares held by Public

No. of public

Type No.of Shares % share holders

Ordinary Shares

136,147,684

46.69

4,072

Non Voting (Class - X) Shares

84,530,840

96.63

4,167

4

Shares held by Director's and Chief executive officers together with the members of their families

Type

No.of Shares

%

Ordinary Shares

320

0.00

Non Voting (Class - X) Shares

7,556

0.01

5

Shares held by the Parent Company

Type

No.of Shares

%

Ordinary Shares

155,441,396

53.31

Non Voting (Class - X) Shares

2,905,204

3.32

6

Directors' and Chief executive officers shareholding together with the members of their families

Non-Voting (Class X)

30.06.2025

30.06.2024

-

-

-

-

556

556

-

-

-

-

-

-

5,000

5,000

2,000

2,000

-

-

7,556

7,556

As at

30.06.2025

30.06.2024

Mr. S.H. Amarasekera - Chairman

-

-

Mr. P.A. Seresinhe (CEO)

-

-

Mr. R.S. Captain

320

320

Mr. S.M. Enderby

-

-

Mr. J.R. Gunaratne

-

-

Mr. D.T.S.H. Mudalige

-

-

Mr. M.P. Jayawardena

-

-

Mr. P.R. Saldin

-

-

Ms. K.D. Senewiratne

-

-

320

320

Share Trading

For the Quarter ended

30th June 2024

Ordinary shares

Non-Voting

(Class X)

No of shares traded

9,878,916

18,455,172

No. of transactions

3,911

7,731

Value of shares traded (Rs.)

1,195,011,064

1,583,120,770

16,445,168

3,781

1,265,648,324

19,950,661

6,394

1,151,203,540